Cite
APA Citation
Michael, M., White, S. C., Abdi, E., Nott, L., Clingan, P., Zimet, A., Button, P., Gregory, D., Solomon, B., Dobrovic, A., Do, H., & Clarke, S. (n.d.). multicenter randomized, open‐label phase II trial of sequential erlotinib and gemcitabine compared with gemcitabine monotherapy as first‐line therapy in elderly or ECOG PS two patients with advanced NSCLC. Asia-Pacific journal of clinical oncology, 11(1), 4–14. http://access.bl.uk/ark:/81055/vdc_100025099772.0x000052